UFUR Plus Thalidomide for Advanced Hepatocellular Carcinoma

NCT00519688 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: Thalidomide
DRUG: Tegafur/Uracil

Sponsor

National Taiwan University Hospital